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Available online 25 March 2011Abstract Unequivocal evidence for pluripotency in which embryonic stem cells contribute to chimeric offspring has yet to be
demonstrated in human or nonhuman primates (NHPs). Here, rhesus and baboons ESCs were investigated in interspecific mouse
chimera generated by aggregation or blastocyst injection. Aggregation chimera produced mouse blastocysts with GFP-nhpESCs
at the inner cell mass (ICM), and embryo transfers (ETs) generated dimly-fluorescencing abnormal fetuses. Direct injection
of GFP-nhpESCs into blastocysts produced normal non-GFP-fluorescencing fetuses. Injected chimera showed N70% loss of
GFP-nhpESCs after 21 h culture. Outgrowths of all chimeric blastocysts established distinct but separate mouse- and NHP-ESC
colonies. Extensive endogenous autofluorescence compromised anti-GFP detection and PCR analysis did not detect nhpESCs
in fetuses. NhpESCs localize to the ICM in chimera and generate pregnancies. Because primate ESCs do not engraft
post-implantation, and also because endogenous autofluorescence results in misleading positive signals, interspecific chimera
assays for pluripotency with primate stem cells is unreliable with the currently available ESCs. Testing primate ESCs
reprogrammed into even more naïve states in these inter-specific chimera assays will be an important future endeavor.
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29Interspecies chimera between primate embryonic stem cells and mouse embryosIntroduction
Pluripotency is now recognized as a spectrum of biological
plasticity rather than an ‘on–off’ toggle switch, and criteria
for assaying pluripotency range from the most demanding
through to less stringent criteria. Certainly, the gold
standard assay involves chimera in which pluripotent stem
cells, both embryonic stem cells (ESCs); (Lallemand and
Brulet, 1990; Nagy et al., 1990; Wood et al., 1993) and more
recently PSCs (pluripotent stem cells); (Takahashi et al.,
2006; Okita et al., 2007; Wernig et al., 2007) have
contributed to both offspring and germ cells after transfer
of either normally fertilized embryos or embryos generated
using tetraploid complementation (Nagy et al., 1990; Eakin
and Behringer, 2003). ESCs are colonies of self-renewing
pluripotent cells that demonstrate the ability to differenti-
ate into all three germ layers in the adult body (Evans and
Kaufman, 1981; Martin, 1981; Thomson et al., 1998). These
and other PSCs promise therapeutic applications for human
disorders and diseases, and contribute further scientifically
as research resources for discovering the fundamental
mechanisms of human development and differentiation
(reviewed by Riazi et al., 2009). Notwithstanding their
potential medical importance, ethical constraints prohibit
vital experiments to determine the safety, efficacy and
therapeutic potentials of human embryonic stem cells
(hESCs); (Daley et al., 2007). Compelling arguments for
prohibiting the use of human induced pluripotent stem cells
(hiPSCs) in reproductive cloning in chimera have been
published (Lo et al., 2010), as have thoughtful considerations
of the biological merits and ethical constraints regarding
using human: animal chimera for biomedical research (Hyun
et al., 2007; Behringer, 2007; Lensch et al., 2007).
Consequently, there exist strong rationales for determining
the full extent of pluripotentiality, as well as the biological
limitations of human- and non-human-primate cells referred
to as ‘pluripotent.'
Clinical extrapolations in stem cell medicine rest on the
solid scientific foundations of a quarter-century of investi-
gations using mouse embryonic stem cells (mESCs) (reviewed
by Evans, 2005). Yet several major concerns remain that
cannot be readily answered by studying hESC cell lines in
vitro or transplanted into relatively short-lived immunocom-
promised mice. These questions include whether nhpESCs
have full pluripotency as assayed in nonhuman primate (NHP)
chimeras, whether differentiated cells remain committed
after transplantation and whether ESCs can proliferate or
migrate uncontrollably. Recently, important findings have
been reported regarding PSC differentiation (Boyd et al.,
2008; Trounson, 2006; Vaca et al., 2006; Mizuseki et al.,
2003; Elkabetz et al., 2008; Kawasaki et al., 2002; Nakatsuji
et al., 2008; Stadtfeld et al., 2008), therapeutic improve-
ments after transplantation (Takahashi, 2006; Takagi et al.,
2005); histocompatibility assays (Dighe et al., 2008; Rajesh
et al., 2007); and epigenetics (Rugg-Gunn et al., 2005a,
2005b; Zhang et al., 2007; Rugg-Gunn et al., 2007; Fujimoto
et al., 2005, 2006; Mitalipov et al., 2007; Mitalipov, 2006).
Lastly, the breakthrough discoveries of inducing pluripo-
tency (iPS); (reviewed by Yamanaka, 2008) using human,
nonhuman primate (Liu et al., 2008), and mouse cells have
dramatically elevated the importance of pluripotency assays
for both fundamental developmental biology as well asmedicine. Importantly, iPSCs from mice have been demon-
strated to result in germ line transmission in both chimeric
embryo assays (Okita et al., 2007, 2008; Wernig et al., 2008)
as well as in tetraploid complementation experiments
(Meissner et al., 2007).
ESC pluripotency has most convincingly been demonstrat-
ed in reaggregated embryos where the resultant offspring
have ESC contributions to all germ layers and tissues,
including the germ line (reviewed by Rossant, 2001). Thus
far, only mouse and rat embryonic stem cells (mESCs)
aggregated with mouse or rat embryos result in offspring
born with demonstrated ESC contribution to all three germ
layers and the germ line (Iannaccone and Jacob, 2009).
Currently, hESC differentiation is assayed by embryoid
bodies (EBs) or teratomas and both contribute to all three
germ layers (Conley et al., 2005), but these technologies
have limitations—EBs do not mimic 3D axial morphogenesis in
vitro accurately and teratomas are a foreign environment
that do not produce germ cells. Overwhelming ethical
concerns obviously preclude interspecific chimera attempts
with hESCs. However, the derivation of nonhuman primate
ESCs (nhpESCs) can responsibly bridge gaps in our scientific
knowledge between mESCs and hESCs, for example, in the
generation of chimeric nonhuman primates with nhpESCs
cells, although issues with NHP embryo availability, cost, and
complex technical obstacles with chimera production remain
(Takada et al., 2002; Schramm and Paprocki, 2004; Scott,
2006; Roberts, 2005). Thus, Mitalipov et al. (Mitalipov et al.,
2006) had previously demonstrated that while derived GFP-
expressing rhesus pluripotent ESCs injected into 4-to-8-stage
fertilized rhesus embryos would incorporate into the
trophectoderm and ICM cells of the expanded blastocyst
grown in vitro, efforts to produce a chimeric monkey after
embryo transfer did not succeed.
Interspecies chimeras have been advanced as an alterna-
tive process for exploring early human developmental
processes and helping address the basic embryology of
hESCs and their potential applications in cell-based therapies
(James et al., 2006). The mouse is the best-characterized
mammalian model and perhaps a logical choice for studying
interspecies chimera: there is an abundance of cheap
embryos and recipients; an enormous background literature
on mESCs already exists; and mouse–mouse chimeras are
well established with regards to genetics, strains and proven
techniques. Furthermore, mESCs are unencumbered by the
material transfer agreement (MTA) restrictions currently
imposed on all NIH Registry hESC lines that explicitly prohibit
their use in animal chimera production. Taken together, the
answers obtained from testing interspecies mouse–NHP
chimeras in utero, after chimeric embryo transfer, and in
vitro might provide new and important information on the
developmental potentials of embryonic stem cells. In
addition, if successful, these intraspecific chimera would
open innovative methods for preserving germ lines from
endangered species (Songsasen and Wildt, 2007; Pukazhenthi
et al., 2006) as well as specialty biomedical research models
(Yang et al., 2008; Chan and Yang, 2009).
Here, we explore mouse–nhpESC chimeras produced with
classic mouse embryo aggregation or blastocyst injection
techniques (Nagy, 2003). Using GFP-expressing rhesus and
baboon nhpESCs, we demonstrate that nhpESCs associate
with the ICM in expanded mouse blastocysts, but rarely
30 C. Simerly et al.proliferate after outgrowth experiments and do not inter-
mingle with mouse tissues, as determined by in vitro
analysis. Furthermore, we show that chimeric mouse–
nhpESC blastocysts transferred to pseudopregnant mouse
recipients produce fetuses but without detectable contribu-
tion from the GFP-expressing nhpESCs, as ascertained by
immunohistochemical, PCR and MRI analysis. Collectively,
we conclude that interspecies chimera between distant
mammals is unfavorable for studying the full pluripotency of
primate ESCs, lending intellectual support for intraspecific
primate chimeric experimentation.Results
The rhesus male line nhpESC 2706 was particularly robust
following transduction with the EF1α-GFP transgene and could
be traced in mouse chimera tissues using monkey-specific
primers to the SRY gene. Supplemental Table S1 summarizes
the various stem cell lines employed for preparing injection- or
aggregation-produced interspecies mouse chimeras. All of the
nhpESCs employed were low passage colonies (range: 7–51) of
good ESC morphology (Fig. S1A) and maintained their plurip-
otent characteristics following transduction with various GFP
transgenes (Fig. S1B), as determined by ‘stemness’ (Fig. S1C;
Table S1) and cell surfacemarker expression (Table S1), as well
as their ability to produce teratomas when injected into NOD-Table 1 Summary of mouse–nhp interspecies chimera fetus pro
[a] [b] [c] [d] [e]
Chimera
type
GFP ESC
cell line
Recipient
type
Total
embryo #'s
transferred
(# of trials)
Total
implantation
sites [IP]
(% of ET)
Mouse 2N
blastocyst-
injection
Rhesus
nhp2706
ICR 147 (9) 56 (38)
Rhesus
nhp106
ICR 60 (3) 25 (42)
Baboon
ESC-4
NOD-SCID 32 (4) 8 (25)
Mouse ESC-
YFP
ICR 48 (4) 16 (33)
Mouse 2N
embryo-
aggregation
Rhesus
nhp2706
ICR 39 (4) 37 (95)
Rhesus nhp
3006
ICR 18 (1) 18 (100)
Mouse ESC-
YFP±bang
particles
ICR 42 (4) 14 (33)
Mouse 4N-
injection
Rhesus
nhp2706
ICR 9 (1) 9 (100)
Rhesus
nhp106
ICR 7 (1) 0
Rhesus
nhp3006
ICR 7 (1) 0
a 2/4 recipients died prior to fetal analysis on day E12 post transfer.
b 9/25 abnormal fetal tissues demonstrated surviving nhpESC-GFP ce
c 5/9 reabsorbing or empty sacs demonstrated surviving nhpESC-GFPSCID strain mice. Additionally, spontaneous differentiation of
GFP-expressing nhpESC colonies in vitro did not silence the
transgene, providing confidence that the primate cells would
maintain GFP detection within interspecific chimera construc-
tion following embryo transfer (Fig S1D–I). Control intraspe-
cific chimeraswere produced by a yellow fluorescent variant of
R1mESCs (7ACS/EYFP; ATCC;Manassas, VA) thatwas germline-
competent and stained positive for pluripotency markers
(Hadjantonakis et al., 2002).
GFP-expressing Rhesus nhpESC lines (Table 1) used in the
aggregation chimera assay produced expanded mouse blasto-
cysts with GFP-expressing nhpESC lines 2706 and 3006
associated with the blastocyst inner cell mass (ICM) cells. We
typically combined mouse zona pellucida-free 2-to-8-cell
stage embryos with Rhesus or Baboon GFP-expressing nhpESCs
(Rhesus: Fig. 1A, arrow) in a depressionwell and cultured them
in vitro until the blastocyst stage (see Figs. S6–S8). After
fixation, confocal optical sectioning (Baboon: Fig. 1B: differ-
ential interference contrast (DIC); 1C: Hoechst DNA, blue)
demonstrated direct fluorescence detection of baboon GFP-
expressing nhpESCs within the ICM (Fig. 1D: GFP, green,
arrowheads). Here, no GFP-expressing baboon nhp 2706ESCs
cells were observed in the outer trophectodermal cells, as
demonstrated with a trophectoderm-specific antibody, CDX2
(Fig. 1E: red; arrow, ICM; composite image, Fig. 1F). We
observed nearly 27% (129/479) of expanded chimera blasto-
cysts with GFP-expressing Rhesus or Baboon nhpESCsduction.
[f] [g] [h] [i]
# Normal
fetuses
recovered
(% of total IP)
# Abnormal
fetuses
recovered
(% of total IP)
# of
reabsorbed/
empty sacs
(% of total IP)
# GFP, YFP or
bang particle
normal fetuses
(% of total IP)
43 (77) 8 (14) 5 (9) 0
25 (100) 0 0 0
5 (63) 0 3 (38) 0 a
12 (75) 0 4 (25) 5 (31)
7 (19) 19 (51) 11 (30) 0 b
2 (11) 6 (33) 10 (56) 0 b
6 (43) 0 8 (57) 5 (36)
0 0 9 (100) 0 c
0 0 0 0
0 0 0 0
1 reabsorbing embryo expressed nhpESC-GFP cells.
lls.
cells.
Figure 1 Generation ofmouse×nhpESC-GFP interspecies aggregation chimera. A: a ‘sandwich’mouse aggregation chimera preparedby
mixing a small clump of GFP-expressing nhp2706 ES cells (green; arrow)with two 2-cell mouse embryos in a depressionwell (arrowheads).
B–F: confocal image of a fixed interspecies aggregation chimera (B: DIC; and C: DNA) produced with GFP-expressing BabESC-4, showing
localization of BabESCs (D: green, arrowheads) at themouse ICM [B,C,E: arrows; E: cdx-2, a trophectoderm specificmarker, red] but not in
the outer trophectodermal cells (F: merged imaged). Similar aggregation chimera w Bar=20 μm.
31Interspecies chimera between primate embryonic stem cells and mouse embryosexclusively in the mouse ICM and another 11% (55/479) with
GFP-expressing Rhesus or Baboon nhpESCs in both the ICM and
trophectoderm. The number of GFP-expressing nhpESCs
associated with the mouse ICM was variable, with a majority
showing 2–5 NHP cells within the ICM of expanded blastocysts.
Time-lapse video microscopy (TLVM) was used to inves-
tigate intraspecific and interspecific chimera formation in
vitro (Figs S6–S8). After 24–48 h of aggregation within a
depression well, compacted embryos with adhering mouse orRhesus nhp ESCs were collected and prepared for TLVM
recording for development to the expanded blastocyst stage.
In intraspecific chimera (mouse×YFP-expressing mouse
ESCs), video evidence suggested that the adhering mouse
YFP-ESC (Fig. S6A–B) would integrate into the mouse during
periods of blastocoel expansion, often as trophectoderm
cells were undergoing division. Interestingly, the expanding
mouse blastocyst did not collapse during the YFP-ESC
incorporation phase, perhaps suggesting that the mouse
32 C. Simerly et al.embryo and mouse ESCs share similar cell surface signaling
molecules that could mediate aggregation. This observation
was similar to control blastocysts lacking the zona pellucida
(not shown), but distinct from observations reported in other
rodents (Gonzales et al., 1996).
Immunocytochemistry analysis of fixed aggregation chime-
ra at the end of the TLVM showed evidence of successful YFP-
mouse ESC incorporation near the site of the mouse ICM
(Supplemental Fig. S6C–F). We next explored interspecific
aggregation chimera formation produced by combining mouse
embryos with unlabeled Rhesus nhp 2706 ESC line. In
aggregation chimera that failed to incorporate the nhpESCs,
the mouse morula stage rapidly expands into a fully expanded
blastocyst. No evidence of breaching the trophectoderm or
incorporation of nhp2706 ESCs into the embryo proper was
observed (Fig. S7). However, incorporation of nhp 2706 ESCs
into the expanding mouse blastocyst appeared to occur just
after a rapid blastocyst collapse (Fig. S8D–E and 8I–J,
arrowheads). These cells appeared to move rapidly towards
the animal pole, or ICM region. Blastocyst collapse is perhaps
caused by the breeching and interjection of nhpESCs through
the tight junction of the adhering outer mouse trophoblast
cells.
We transferred mouse 2N embryo aggregation chimera
produced with GFP-expressing nhp 2706 or 3006 ES cell lines
into ICR strain recipients to investigate fetal contributions in
vivo (Table 1). Of 57 total aggregation chimera transferred to 5
recipients, we observed 55 (96%; Table 1, column e)
implantation sites but only 9 (16%; Table 1, column f) normal
fetuses. The vastmajority of the tissues recoveredwere either
abnormal (25 total; 45%; Table 1, column g) or being
reabsorbed (21 total; 38%; Table 1, column h). None of the
fetuses recovered demonstrated GFP-expressing nhpESCs
(Table 1, column i). Microscopic analysis of the fetal tissues
recovered from embryos produced with rhesus GFP-expressing
nhp2706 cell line showedmany instances of axial abnormalities
(head–trunk: Fig. 2A) and delayed fetal development (Fig. 2C)
but no detectable GFP-expressing cells (Fig. 2B–D). In several
instances, surviving GFP-expressing 2706 ES cells were
observed in reabsorbing implantation tissues (Fig. 2E, bright-
field; 2F, GFP, green, arrowheads). Thus, aggregation
chimeras with GFP-expressing nhpESCs produced mosaic
blastocysts with varying number of GFP cells associated with
themouse ICM and high numbers of abnormal fetuses following
embryo transfer to pseudopregnant recipients.
Next, we explored interspecies chimera after GFP-
expressing nhp 2706 or 106 ESCs were injected into the
expandedmouse blastocysts. We first determined the survival
of injected nhp2706 ESCs within the mouse blastocoel niche.
Chimeras were produced bymicroinjecting a known number of
GFP-expressing nhp2706 ESCs into expanded mouse blasto-
cysts (Fig. S2A), placing the GFP-expressing cells adjacent to
the mouse ICM (Fig. S2B). As shown, within 4–6 h, the re-
expanded mouse blastocysts (Fig. S2C) demonstrated GFP-
expressing nhp2706 ESCs in the blastocoel, some localized at
the mouse ICM (Fig. S2D: GFP, green). However, only 43% [10/
23] of injected blastocysts retained any GFP-positive nhp2706
ESCs after 21 h of in vitro culture and fluorescent analysis of
surviving GFP-nhp2706 ESCs revealed N70% loss of the total
number of cells. We then performed embryo transfers of
injected interspecies chimeric blastocysts to pseudopregnant
ICR or NOD-SCID mice after using either rhesus or baboon GFP-expressing ESCs. We observed several implantation sites (ICR:
81/207 [39%]; NOD-SCID: 8/32 [25%]; Table 1, columns d–e)
and a high percentage of normal E10.5 fetuses at recovery
(ICR: 68/81 [84%]; NOD-SCID: 5/8 [63%]; also Fig. S3).
However, none of the normal fetuses expressed GFP
(Table 1; column i; Fig. S3). Conversely, from 48 embryo
transfers using control intraspecific chimeric blastocysts
produced with YFP-expressing mESCs, 16 implantation sites
(33%; Table 1, column e) and 12 normal fetuses (75%; Table 1,
column f) were recovered, with 5 fetuses expressing YFP (31%;
Table 1, column i; see also, Fig. S3). Microscopic analysis of
injection chimeric embryos produced with GFP-expressing
Rhesus nhp 2706 ESCs (Fig. 3) or GFP-BabESC4 cell lines
(Fig. S4) in either ICR or NOD-SCID recipients demonstrated no
GFP expression in the tissues of recovered normal fetuses
(Rhesus 2706: Fig. 3A–B; BabESC-4: Fig. S4A–B). Various
abnormal embryos were largely negative for GFP detection
also (Rhesus 2706: Fig. 3A–B), although occasional GFP ‘dots’
were observed in some recovered abnormal tissues (Rhesus
2706: Fig. 3E, brightfield; 3F, GFP, green, arrowheads; Fig.
S4E, brightfield; Fig. S4F, GFP, green, arrowhead; BabESC-4:
Fig. S4C, brightfield; S4D: GFP, green, arrowheads). Mouse
intraspecific embryos produced with YFP-expressing mESCs
and transferred to pseudopregnant recipients showed exten-
sive fluorescence throughout the E10.5 day fetus (Fig. 3G–H;
YFP, yellow).
Mouse–nhpESC chimeras were also prepared using the
mouse tetraploid complementation assay (Nagy, 2003). We
electrofusedmouse 2-cell embryos to produce 4N embryos and
permitted these to develop to the expanded blastocyst stage
before injecting them with GFP-expressing nhpESCs and
performing embryo transfers to ICR pseudopregnant recipi-
ents. Harvest of fetal material around E12.5 showed high
implantation sites with chimera prepared with nhpESC 2706
ESCs (Table 1, columne), but no normal fetal development and
mostly necrotic or reabsorbing implantation sites upon
sacrifice (Table 1, column h).
To analyze mouse–nhpESC chimeras at the cellular level, a
few normal E12.5 fetuses were selected for immunohisto-
chemical analysis (Fig. S5). We counterstained 10 μm sections
with anti-GFP antibody to compare with any detected GFP
expression. Preliminary analysis of ectoderm (spinal cord
tissue: Fig. S5A1),mesoderm (pericardial tissue: Fig. S5B1) and
endoderm (urogenital tissue; Fig. S5C1) layers in an interspe-
cies fetus suggested extensive survival of GFP-expressing cells
that co-localized precisely with anti-GFP staining (Fig. S5A2,
S5B2, and S5C2). However, control tissue sections from a
fertilized E12.5 day mouse embryo suggested extensive auto-
fluorescence following fluorescein and rhodamine excitation
in a variety of tissues, rendering fluorescent analysis unreliable
(fluorescein excitation: Fig. S5A3, S5B3, and S5C3; rhodamine
excitation: Figs. S5A4, S5B4, and S5C4). Efforts to control for
endogenous fluorescence by using various blocking agents
prior to application of primary and secondary antibodies were
not successful (our unpublished data).
On selected interspecies embryos produced with GFP-
expressing rhesus nhp2706 ESCs (a male line), we explored if
SRY and GFP DNA could be detected by PCR analysis (Fig. 4).
For a positive control, we used DNA isolated from a
transgenic male monkey carrying the GFP transgene (ANDi)
(Chan et al., 2000), demonstrating the detection of SRY DNA
(Fig. 4, lane 3) and GFP DNA (Fig. 4, lane 14). However, no
Figure 2 Developmental abnormalities in interspecies aggregation chimera at E10.5 prepared with GFP-expressing nhp 2706 ESCs.
A–B: head–trunk axial deformity (A: BF; arrowheads, A: anterior head region; P: posterior trunk region) in an aggregation chimera. No
GFP expression was observed (B: green). C–D: severely delayed embryonic development (C: BF), but no discernible GFP expression
(D: green). The tail region was slightly damaged during dissection from the decidual sac. E–F: an implantation site without a definable
embryo (E: BF) but with a few GFP expressing cells (F: green, arrowheads). BF: brightfield optics; A: anterior head region; P: posterior
trunk region. Bars=500 μm.
33Interspecies chimera between primate embryonic stem cells and mouse embryosDNA from the embryonic tissues of these interspecies
chimeras produced positive bands with primers from either
SRY (Fig. 4, lanes 4–6) or GFP (Fig. 4, lanes 9–13), suggesting
that no nhpESCs had survived in the developing mouse
fetuses. Analysis of an interspecies chimeric blastocyst
outgrowth produced with GFP-expressing nhp2706 ESCs also
did not detect SRY DNA after 1 month in culture (Fig. 4, lane
2). This particular colony did not demonstrate GFP expres-
sion in surviving cells after a few days of culturing in vitro.
Finally, we investigated GFP-expressing nhpESC survival,
proliferation and integration with mouse cells in vitro
following blastocyst outgrowth on sterile coverslips(Fig. 5). Chimeric injection blastocysts outgrown for 3 days
showed that GFP-expressing cells remained largely clustered
together without significant intermixing with mouse cells
(Fig. 5A–C). Likewise, aggregation chimeric blastocyst
outgrown for 17 days in vitro (Fig. 5D–F) demonstrated
that while the GFP-expressing nhpESCs proliferated over the
2 weeks in culture, the nhpESCs did not integrate into the
mouse ICM cellular area (Fig. 5D–F, * indicates mouse
differentiated cells derived from the mouse ICM). Regard-
less, the survival of pluripotent, GFP expressing nhpESCs in
mouse chimeric blastocyst outgrowths were low (~2.5%)
overall.
Figure 3 Chimeric blastocyst injection embryos at E10.5 day post embryo transfer. A–B: Normal embryo produced from a
mouse×GFP nhp2706-ESC injection chimera (A: BF), but without GFP expression (B: green). C–D: An abnormal mouse embryo (C: BF)
derived from the transfer of a mouse×GFP-expressing nhp2706-ESCs injection chimeric. No GFP expressing cells are seen in the
disorganized tissue (D: green, GFP). E–F: a reabsorbing mouse embryo (E: BF) derived from a mouse×GFP-expressing nhp2706-ESCs
injection chimeric. A few GFP-expressing cells are observed in the fetus (F: green, arrowheads). G–H: Control chimeric embryo
derived from a mouse×YFP-mouse ESCs blastocyst transfer into an ICR recipient. The normal embryo (I: BF) expresses YFP in many
tissues (J: YFP). BF: bright field; GFP: green fluorescent protein. All embryo transfer were performed in ICR recipients. All chimera
were produced with GFP-expressing rhesus 2706 male ESC line. Bar=500 μm.
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The contribution of ESCs and other PSCs to chimeric offspring
resulting in germ-line transmission is the most stringent
assay for demonstrating biological pluripotency (reviewed byBehringer, 2007). This chimera assay has resulted in significant
insights into the various categories of PSCs, even with mice,
since embryonal carcinoma, embryonic germ, ESCs and PSCs
generated by induced pluripotency all pass this test, whereas
stem cells from epiblasts do not (Tesar et al., 2007; Brons
Figure 4 PCR analysis of SRY (Left) and GFP (Right) DNA in embryos derived from mouse blastocyst injected with GFP nhp ESC 2706
male line. Lane 1: DNA marker; lane 2: chimeric outgrowth without GFP positive cell expression; lane 3: positive DNA control
(transgenic monkey cells from ANDi); lanes 4–6: embryos derived from an injection chimera attempt (mouse×GFP nhpESC 2706 cell
line); lane 8: DNA marker; lanes 9–13: embryos derived from an injection chimera (mouse×GFP nhpESC 2706 cell line); lane 14:
positive DNA control (ANDi cells); lane 15: blank.
35Interspecies chimera between primate embryonic stem cells and mouse embryoset al., 2007). Epiblast SCs, inwhich Lif signalingwas introduced
transgenically (Bao et al., 2009), were shown to have regained
the ability to participate in chimeric development andFigure 5 Interspecies chimeric outgrowth. A–C: Confocal imaging o
ESCs at day 3 post-outgrowth. The GFP-nhpESCs remain clustered
B: Hoechst DNA; C: merged image. D–F: Sequential fluorescent
aggregation chimeric blastocyst produced with male GFP nhp2706 E
onto the MEF feeders with extensive GFP nhpESCs at the mouse ICM (D
(E: *) are distinctly separate from the expanding GFP-nhpESCs (E
outgrowth, rapid proliferation of the GFP-expressing nhpESCs along a
is observed, with little intermixing of the mouse: monkey ESCs. Magtransmit to the germ-line, demonstrating that the loss of this
signaling cascade during post-implantation development re-
sults, in part, with this diminishment of pluripotency.f a mouse blastocyst injected with male GFP-expressing nhp2706
together (A: green) without intermixing with mouse ICM cells.
and Hoffman Modulation Contrast (HMC) images of a mouse
SCs. At day 2 post outgrowth, the chimeric blastocyst attaches
: green). On day 8 post-outgrowth (E), the expanding mouse ESCs
: green; inset, details of GFP-nhpESCs). On day 17 days post-
distinct border of the largely differentiated mouse ESC colony (*)
=100×; Bar=20 μm.
36 C. Simerly et al.Chimera have been generated in the lab exclusively as
interspecific chimera between mouse species (Rossant and
Frels, 1980) and recently rats (review by Iannaccone and
Jacob, 2009). Even within the rodent family, intergeneric
chimerabetweenmice and voles did not succeed (Mystkowska,
1975a, 1975b). In domestic species, intergeneric chimerawere
first generated between sheep and goat embryos more than
sixty years ago (Warwick and Berry, 1949) while interspecific
chimera between European and indigenous Asian cattle have
also been generated (Williams et al., 1990). Pregnancies
generated by the ovine–caprine intergeneric chimera succeed
to term but only at low frequencies (Gustafson et al., 1993;
Jaszczak et al., 1999) demonstrating the loss of chimera
proportions as these animals age post-natally.
Among the several rationales for this study, four are most
prominent. First, it is important to understand the develop-
mental biology of embryonic stem cells, as well as other lines
now classified within the constellation of pluripotent stem
cells. While the fundamental science of this field is on firm
foundations with the decades of confirmed reports using
mouse ESCs, results in other species, including humans and
other primates, rest on less sure footings. Related to this point,
the enormous expansion of the PSC field as well as
understandable regulatory constraints on using hESC chimera
assays has resulted in the proliferation of numerous alternative
pluripotency assays with various degrees of leniency. Indeed,
if pluripotency is viewed as a scale in which assays are rated
from greatest stringency to most permissive, then germ-line
transmission in tetraploid embryo complementation would be
considered at the most reliable. Perhaps less stringent would
be fertilized embryo chimera. Owing to the interest in human
ESCs, in which only one group has reported chimeric assays
(James et al., 2006), teratoma assays serve as the most
stringent test for pluripotency in which tissues from the three
germ layers are examined. Notwithstanding the practicality of
these teratoma assays, organogenesis and patterning are
chaotic and the extent of germ layer contributions is rarely
quantified. Embryoid bodies and in vitro differentiation, either
spontaneous or directed, are perhaps mid-scale on this
pluripotency assay ruler. The detection of pluripotency
markers by fluorescence (i.e., Oct-4, NANOG, SSEAs, and
Tra-1-antigens) is problematic due to problems of autofluor-
escence, cross-reactivity as well as non-specific expression.
RT-PCR is extraordinarily sensitive which forces questions
about whether minute numbers of contaminating cells might
generate misleading results. Notwithstanding the power of
transcriptional analysis and its potential contributions for
system biology, the reliability of these in silica approaches for
unequivocal demonstrations of biological pluripotency re-
mains to be confirmed. Consequently, the prime rationale for
this investigation was to determine in a relevant biological
assay the post-implantation potential of nhpESCs in murine
chimera.
Secondly, the field of pluripotency is rapidly influencing the
design of futuremedical approaches. Withmice, few concerns
are raised as to whether a transgenic insertion of GFP might
influence the outcome of experiments, thus the importance of
more reliably understanding various increases in perturbations
as fundamental studies move towards clinical applications.
Against this background, James et al. (2006) conducted a
complicated set of experiments in which they first established
a unique hESC line which was free from the MTA (materialtransfer agreements) of the traditional stem cell supplies,
since those MTAs prohibit the introduction of hESCs into the
reproductive systems of mammals or the combination of hESCs
with embryos for reproductive purposes. Also, they were able
to conduct their investigations without federal funding re-
strictions that preclude these types of experiments. This study
suggested that human ESCs introduced into mouse blastocysts
by either aggregation or blastocyst injection survived within
the mouse ICM niche and proliferated into differentiated
human derivatives. Furthermore, the human ESCs were
described as integrated into early embryonic mouse tissues
following embryo transfer to pseudopregnant females. Not-
withstanding heroic efforts in performing these investigations,
questions remain regarding whether the introduced hESCs
proliferated and participated in post-implantation develop-
ment. Perhaps they were ‘bystanders’ surviving on the
sidelines and swept up in the morphogenetic migrations.
Questions have been raised as to whether the foci detected by
fluorescence might even have been adventitious. Perhaps the
hESC line generated from anonymously-donated clinically-
discarded specimens might have been subprime owing to its
origins. Consequently, we undertook these studies using
embryos generated by fertile pedigreed primates for the
express purpose of generating top-quality ESC lines with the
best chances for full biological pluripotency.
Third, beyond fundamental and preclinical significance,
the importance of chimeric assays using nonhuman primates
extends into the realm of invaluable research resources.
Investigations using nonhuman primates are expensive and
cumbersome, yet important to bridge the gap from funda-
mental discoveries in mouse models to clinical investigations.
Were PSCs from NHPs to turn out useful in generating chimeric
offspring, a significant number of investigations could be
performed in vitro with only the last confirmatory studies
conducted on specialty primates, as is the case withmice. The
opportunity to modify primate research resource require-
ments using chimera would be rather significant, especially as
innovative research models (reviewed by Schatten and
Mitalipov, 2009) are emerging, including transgenic primates
(Yang et al., 2008; Chan et al., 2000), NHPs with discordant
mitochondrial and nuclear genetics (Tachibana et al., 2009),
and perhaps reproductive clones soon.
Fourth, bioethical considerations regarding chimera be-
tween human cells and animal embryos, related concerns
involving transfer of human nuclei into enucleated animal
oocytes [cybrids], as well as actual hybrids are topics of active
debate (Chapman and Hiskes, 2008; St John and Lovell-Badge,
2007). To help ground these bioethical conversations on a
firmer foundation, this investigation, using nonhuman primate
stem cells chimerized into mouse embryos, was designed to
address the biological feasibilities of this assay. It is important
to note that in contrast to the human ESCs available, these
primate lines were all generated from fertile pedigreed
primates where the best quality embryos were selected from
ESC derivations. Should chimeric fetuses or animals be
generated using pluripotent stem cells and either interspecific
or intraspecific animal embryos, then the biological founda-
tion for this experimental manner of reproduction would
underscore the recent calls to prohibit hiPSCs for reproductive
cloning (Lo et al., 2010).
Here, we demonstrate that chimeric embryos generated
by combining mouse embryos with nhpESCs from either
37Interspecies chimera between primate embryonic stem cells and mouse embryosrhesus or baboons are not detected after implantation, even
when the primate cells localize to the ICM in both aggregated
and injected embryos. Aggregation chimera display numer-
ous nhpESCs at the mouse ICM but fetal development after
embryo transfers is significantly impaired (Fig. 2; Table 1),
while chimera generated by blastocyst injection have fewer
nhpESC within ICM but the surviving fetuses are more
developmentally normal (Fig. 3; Table 1). Consequently,
we suggest that these interspecific chimeric embryos may
have limited pre-clinical utility for analyzing the pluripotent
status and developmental capabilities of primate ESC.
Autofluorescence in mouse tissues raises significant
concerns of ‘false positive’ interpretations. In Fig. 6, we
present an immunohistochemistry analysis of fetal tissues
both before and after introduction of the anti-GFP antibody.
The danger of premature enthusiasm from extensive mouse
fetal autofluorescence is quite high (Fig. 4). However, the
survival and/or participation of monkey ESCs in fetal mice
were either below detection sensitivity or perhaps precluded
by biological incompatibilities. PCR analysis using specific
primers to the monkey SRY gene or GFP did not detect the
presence of male GFP-expressing nhpESCs in the tissues of
mid-stage embryos (Fig. 5). Additionally, we explored
tracing ESC participation in developing mouse chimera
using high magnetic field MRI microscopy. Mouse YFP-
expressing ESCs pre-labeled with Bangs™ beads, superpar-
amagnetic microparticles detectable by MRI (Shapiro et al.,
2004), were used to prepare mouse chimeric blastocysts
following aggregation or injection into mouse blastocysts.
However, despite 38% mouse chimeric production following
transfer to pseudopregnant females (Table 1), as assayed by
GFP expression, we could not detect the Bangs beads by MRI
microscopy as have been previously reported (Shapiro et al.,
2004) imaging, perhaps owing to particle levels below MRI
detectable thresholds within the tissues. Newer methods
coupling transgene reporters with ferritin may be more
suitable for investigating individual cell contribution to
chimeric tissue and organs (Ahrens et al., 2006; Mills and
Ahrens, 2009; Genove et al., 2005).
It is tempting to speculate that differences in the cellular
adhesiveness between rodents and primates preclude their
migration during gastrulation and beyond. It appears that
ESCs prefer to adhere with cells of their own species and
perhaps this specific–specific differential adhesion accounts
for the results here. When outgrowths of these interspecific
nhpESC–mouse chimeras are established, the murine cells
appear to grow separately from the growing nhpESC ones,
i.e. the surviving colonies do not intermix, but self-select to
‘like’ cells (Fig. 6). Perhaps the adhesive requirements for
cells to remain attached during the morphogenetic move-
ments at gastrulation block nhpESC contribution to the
developing fetus because their association with the murine
cells is too weak.
Perhaps cell cycle differences between primate and
rodent pluripotent stem cells preclude primate ESCs from
participation in development after implantation. The time
course of development also differs significantly between
rodents and primates. Blastocysts develop in mice within
3.5–4 days, whereas human blastocysts require 5–6 days and
nhp primates a week or more. Perhaps differences in cell
cycle influence the relative proliferation of nhpESCs within
the differently timed mouse embryo. It is also worth notingthat whereas mouse gestation is around three weeks, rhesus
and baboons require over a half-year.
Recent evidence has shown that human ESCs have similar
characteristics to mouse epiblast stem cells (EpiSCs) rather
than mouse ESCs. Like hESCs, mouse EpiSCs demonstrate
similar dependence on bFGF/Activin signaling, grow in
flatter colony morphologies with slower growth patterns
compared to mESCs, and show similarities in X-chromosome
inactivation (Tesar et al., 2007; Brons et al., 2007). Also,
since mouse EpiSCs do not typically produce chimera in
intraspecific chimera assays, it may be that nonhuman
primate ESCs will also be poor candidates for chimera
production in monkey: monkey chimera attempts. However,
methods are now being discovered that permit intraconvert-
ibility of human ESCs into more murine ESC-like states
(Nichols and Smith, 2009; Buecker et al., 2010; Kerr and
Cheng, 2010; Xu et al., 2010). Hanna et al. (Hanna et al.,
2010) recently demonstrated that hESCs can be repro-
grammed into a more mouse ESC like states with regards to
gene expression profiles, X chromosome inactivation in
female lines, and Lif/Stat3 signaling. While human PSCs
cannot be used for intraspecific chimera attempts, repro-
gramming nonhuman primate ESCs into this naïve state can
be tested to determine if it improves interspecific chimera
results for the demonstration of full pluripotentiality as well
as for enhanced biomedical utility of these preclinical
research resources.
Conclusions
ESCs from both baboons and rhesus integrate into the ICM of
mouse blastocysts in both aggregation and injection chimera,
but they are lost after implantation. This suggests that
interspecies chimera may have limited pre-clinical diagnostic
utility for determining the developmental potentials of cells
from primates. Regardless, the likelihood that primate ESCs
may participate in chimeric development in intraspecific
embryos remains both with currently available nhpESCs and
perhaps more successfully with naïve nhpESCs.
Material and methods
Mice
Female F1 B6D2F1 mice (Harlan Sprague Dawley, Indianap-
olis, IN) were hormonally superstimulated, bred to fertile
males, and collected as described previously (Simerly and
Schatten, 1993). ICR or NOD-SCID strain females mated to
vasectomized ICR males (Harlan) produced pseudopregnant
female recipients for embryo transfers (ETs) (Nagy, 2003).
ESC lines
Mouse YFP-expressing embryonic stem cells (mESCs) were
obtained commercially (ATCC; Manassas, VA) and cultured as
described (Hadjantonakis et al., 2002). Nonhuman primate
embryonic stem cell lines were derived and maintained on
mitomycin-C inactivated primary mouse embryonic fibro-
blasts (MEFs) on 0.1% gelatin-coated dishes as previously
described (Navara et al., 2007a; Simerly et al., 2009).
38 C. Simerly et al.Supplemental Table S1 list the pluripotency marker charac-
teristics and teratoma data outcomes for 3 transduced
Rhesus lines (nhp 2706; nhp 3006; and nhp 106) and 1 baboon
line (BabESC-4) employed for this study. All NhpESCs colonies
were mechanically passaged weekly with culture medium
changed every 48 hours. GFP transduction of nhpESC lines is
described in the Supplemental data.
Interspecies chimera production
Colonies of YFP-mESCs or GFP-nhpESCs were briefly treated
with 0.05% trypsin-EDTA (45 s) at 37 °C,mechanically scraped,
and washed once. Aggregation chimeras were prepared by
combining zona pellucida-free mouse embryos (4-to-8 cell
stage) with small clumps (~10–50 cells) of transduced mouse
or monkey ESCs in depression wells (Nagy, 2003) using the
appropriate stem cell media. Aggregations were grown until
the expanded blastocyst stage and analyzed for incorporation
at the mouse blastocyst ICM using attenuated fluorescent
exposure (b5 s) on a Nikon TE-300 inverted microscope.
For injection chimeras, small clumps of transducedmouse or
monkey ESCs were microinjected into expanded mouse blasto-
cysts using beveled pipettes (17 μm; Humagen, Charlottesville,
VA). Injected mouse blastocysts were recovered 6 h before ETs
into pseudopregnant recipients. Methods for producing tetra-
ploidmouse chimeric embryos are provided in the Supplemental
Data.
Outgrowths
The zona pellucida of aggregation- or injection-produced
expanded chimeric mouse blastocysts were removedwith acid
Tyrode's (Specialty Media, Millipore Corporation, Bedford,
Mass), recovered for 30 min, and then plated onto MEFs in
rhesus stem cell media (Navara et al., 2007b). Media changes
were performed every 48 h and images taken by inverted HMC
and fluorescence optics.
Embryo transfers and fetal recoveries
Chimeric blastocysts produced by aggregation or injection
methods were transferred into the uterine horns of day 2.5
pseudopregnant ICR or NOD-SCID females using aseptic
techniques (Nagy, 2003). Analysis of fetal development in
recipients was performed between E12–17.5 days. Bright-
field and fluorescent photographs were taken of excised
fetuses using a Nikon Digital Sight DS-5MC CCD on a Nikon
SMZU dissecting scope (Nikon USA, Melville, NY). Digital
images were archived using MediaView software (Molecular
Devices, Sunnyvale, CA). Abnormal embryos were given GD
(growth disorganization) scores as described Poland et al.
(Poland et al., 1981).
Immunocytochemistry, Immunohistochemistry, PCR, and
Time-lapse Video Microscopy (TLVM) details are described in
the Supplemental data.
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